BK channels were demonstrated as a molecular target of several drugs for ischemic stroke therapy including vitamin C (Li L. et al., 2019), chlorpromazine (Li et al., 2014), and Baifuzi (Chi et al., 2010). Here, KCNMA1 is linked to ischemic stroke.